23948sdkhjf
Logga in eller skapa en prenumeration för att spara artiklar
Få tillgång till allt innehåll på Medtech Magazine
Ingen bindningstid eller kortinformation krävs
Gäller endast personlig prenumeration.
Annons
Annons
Innehållet nedan modereras inte i förväg och omfattas därmed inte av webbplatsens utgivningsbevis.
Dela sida
Sponsrat innehåll

UK plans permanent recognition of CE-marked medical devices

Good news for medical device manufacturers targeting the UK market.

The UK has announced plans to permanently recognize CE-marked medical devices compliant with the EU MDR and IVDR, removing the previously planned 2030 deadline for CE recognition in Great Britain. UKCA will remain available as an alternative route to market.

For manufacturers, this could mean greater regulatory predictability and avoiding the need for parallel certification processes when accessing markets in England, Scotland and Wales.

However, CE recognition does not remove all UK-specific requirements. MHRA registration and the requirement for manufacturers outside the UK to appoint a UK Responsible Person (UKRP) will remain.

The legislative changes are expected to be implemented before 30 June 2028, subject to parliamentary approval.

A welcome step towards a more predictable regulatory environment for the medtech industry.

If you’re planning to enter the UK market or have questions regarding UK-specific regulatory requirements, contact us. 

Our experts support non-UK manufacturers with UKRP services to make UK market access straightforward, efficient, and compliant—so they can move forward with confidence.

Learn more about Aurevia’s UKRP services

Aurevia
Box 150 27
750 15 Uppsala
Uppsala kommun
Sverige
VAT nummer: SE5565873147

Kontaktperson

Anna-Karin Alm
Head of QARA
anna-karin.alm@aurevia.com
Annons Annons
BREAKING
{{ article.headline }}
0.078|instance-web01